Label: ANTI-WRINKLE FIRM LIFT CREAM cream

  • NDC Code(s): 84756-331-01, 84756-331-02, 84756-331-03, 84756-331-04, view more
    84756-331-05
  • Packager: Guangzhou Lifubao Cocmetics Co., Ltd.
  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated November 13, 2024

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • COMPONENTS

    Salicylic acid 2%

  • PURPOSE

    wart remover

  • INDICATIONS & USAGE

    Apply twice daly(moring and night as a man and once as a woman.Afer apicaion, proeed with an acive masage for 3-5 minutes unthe product is fuy absorbed

  • WARNINGS

    Forevemaluseony Avoid coniac wth eves li coniac ocus nse ihorouthly wt waier Keep out ofreach oi chidrenifvou ale preanant.nursing. otiaveanyunderving medca condion.consutyou healthcare provider before using the product

  • DOSAGE & ADMINISTRATION

    For external use only.

  • DO NOT USE

    Discontinue use if any irritation or adverse reaction occurs

  • WHEN USING

    When using this product, avoid contact with eyes. lf contact occurs, rinse thoroughly with waterDiscontinue use if any irritation or adverse reaction occurs.

  • STOP USE

  • KEEP OUT OF REACH OF CHILDREN

    If sxralowed, get medical help or contact a Poison Conirol Cenler ngiht away.

  • INACTIVE INGREDIENT

    Acrylates copolymer, Ethyl acetate

  • PRINCIPAL DISPLAY PANEL

    Label

  • INGREDIENTS AND APPEARANCE
    ANTI-WRINKLE FIRM LIFT CREAM 
    anti-wrinkle firm lift cream cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84756-331
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE5 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    GLYCERIN (UNII: PDC6A3C0OX)  
    SESAME OIL (UNII: QX10HYY4QV)  
    PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M)  
    CHLORPHENESIN (UNII: I670DAL4SZ)  
    PALMITOYL PENTAPEPTIDE-4 (UNII: KK181SM5JG)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:84756-331-015 g in 1 BOX; Type 0: Not a Combination Product11/13/2024
    2NDC:84756-331-0215 g in 1 BOX; Type 0: Not a Combination Product11/13/2024
    3NDC:84756-331-0330 g in 1 BOX; Type 0: Not a Combination Product11/13/2024
    4NDC:84756-331-0450 g in 1 BOX; Type 0: Not a Combination Product11/13/2024
    5NDC:84756-331-05100 g in 1 BOX; Type 0: Not a Combination Product11/13/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01611/13/2024
    Labeler - Guangzhou Lifubao Cocmetics Co., Ltd. (698835114)
    Establishment
    NameAddressID/FEIBusiness Operations
    Guangzhou Lifubao Cocmetics Co., Ltd.698835114manufacture(84756-331)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!